Study guide
6.2 Controlled Substance Prescribing & the NY EPCS Mandate
New York MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy
2 Federal Pharmacy Law: Controlled Substances
2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)
3 Federal Pharmacy Law: Privacy & Supply Chain
3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity
4 Area 1a: NYSED, Board & Pharmacist Licensure
4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education
5 Area 1b: Interns, Technicians & Discipline
5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs
6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice
6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders
7 Area 2b: Counseling, Immunization & Public Health
7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records
8 Area 3a: Verification, Transfers & DUR/I-STOP
8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing
9 Area 3b: Labeling, Packaging & Substitution
9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales
10 Area 4a: Records, Inventories & Delivery
10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing
11 Area 4b: Compounding, Central Fill & Facilities
11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline
12 Test-Day Strategy & Final Review
12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps
6.2 Controlled Substance Prescribing & the NY EPCS Mandate
Key Takeaways Explain This Topic AI
New York's I-STOP law (Chapter 447 of the Laws of 2012, codified at PHL §281) made electronic prescribing mandatory for both controlled (Schedule II-V) and non-controlled substances effective March 27, 2016, after a one-year enforcement delay from the original March 27, 2015 date.
PHL §281(3) lists five statutory exceptions to the mandate: veterinarians, temporary technological/electrical failure, a Commissioner-granted waiver (up to 1 year, renewable), patient timely-access impracticality (controlled substance quantity capped at a 5-day supply), and out-of-state dispensing.
A separate low-volume certification under PHL §281(7) — distinct from the hardship waiver — lets a practitioner who will issue 25 or fewer prescriptions in a 12-month period file a one-year, renewable certification instead.
When an electronic prescription fails to transmit, a 'failover fax' is never a valid substitute; the prescriber must issue a manually signed Official New York State Prescription (ONYSRx) or, where an oral exception applies, an oral replacement.
Willful violation of New York's electronic prescribing mandate is a misdemeanor punishable by imprisonment and/or a fine of up to $10,000, with the compliance burden falling on the prescriber, not the pharmacy.
Last updated: July 2026
The I-STOP Law and the March 27, 2016 Mandate
New York's electronic prescribing mandate traces to the Prescription Drug Reform Act , enacted as Chapter 447 of the Laws of 2012 and commonly known as I-STOP (Internet System for Tracking Over-Prescribing). I-STOP is codified at Public Health Law (PHL) §281 (Article 2-A, Title III) and Education Law Article 137, §6810 , with implementing rules at 10 NYCRR Part 80 . Electronic prescribing of controlled substances became legally permissible in New York on March 27, 2013, giving prescribers a three-year runway before it became mandatory . The mandate was originally scheduled to take effect March 27, 2015, but the Department of Health delayed enforcement by one year over prescriber-readiness concerns. Electronic prescribing became mandatory for both controlled and non-controlled substances effective March 27, 2016 , making New York one of the first states in the country to require electronic prescribing this broadly.
Two scope points matter for the MPJE: first, the mandate covers all five controlled substance schedules (II-V) , not just Schedule II; second, it also covers non-controlled ("legend") drug prescriptions — a scope broader than the federal EPCS framework, which addresses only controlled substances. Before issuing electronic controlled-substance prescriptions, a prescriber must complete DEA identity proofing, obtain a federally compliant two-factor authentication credential, and register the certified EPCS software application with the New York State Bureau of Narcotic Enforcement (BNE) .
Statutory Exceptions — PHL §281(3)
- Exception Basis Key Detail
- Veterinarians §281(3)(a) Categorically excluded by nature of license
- Technological/electrical failure §281(3)(b) Temporary, as defined in regulation
Commissioner waiver §281(3)(c) Up to 1 year, renewable; granted for economic hardship, technological limitations outside the prescriber's control, or other exceptional circumstance
Patient timely-access impracticality §281(3)(d) Prescriber determines e-prescribing would delay the patient's timely access and adversely affect the patient's condition; if the drug is a controlled substance, quantity is capped at a 5-day supply
Out-of-state dispensing §281(3)(e) Prescription will be filled at a pharmacy located outside New York
Practitioners do not have to note which exception applies on the face of the prescription, and pharmacists are not required to verify the reason — but the pharmacist should still recognize when a paper or oral order falls outside all five categories and push back.
The Low-Volume Certification — a Separate Track (PHL §281(7))
Distinct from the waiver process, PHL §281(7) lets a practitioner who will issue 25 or fewer prescriptions in a 12-month period file a certification — not a waiver — with the Department. The 25-prescription count combines oral and written prescriptions, controlled and non-controlled substances alike. A certification is valid for one year and must be renewed; it does not require the hardship showing a §281(3)(c) waiver does.
Administrative Blanket Waivers and Federal-Property Prescribers
Beyond individually granted waivers, the Department of Health has issued and annually extended blanket waivers under the general §281(3)(c) authority for practitioners serving nursing home and home-care/hospice residents , citing the operational realities of nursing-home EHR platforms and multi-site prescribers who are not on-site around the clock. Separately, prescribers who practice solely on federal property — a Department of Veterans Affairs (VA) facility, for instance — fall outside New York State's jurisdiction for that federal-property prescribing and do not need to register their EPCS software with BNE for it; if the same prescriber also writes prescriptions off federal property elsewhere in New York, the software used for that off-property prescribing must be separately registered.
When an Electronic Prescription Fails to Transmit
New York draws a hard line here: an intermediary may never convert a failed electronic transmission into a fax as a workaround. Education Law §6802 excludes facsimile transmission from the statutory definition of "electronic prescription," so a "failover fax" carries no legal force as a prescription — at most, it functions as an informational courtesy notice to the pharmacy. When true transmission failure occurs, the prescriber must fall back on one of the lawful non-electronic paths already discussed: issue a manually signed Official New York State Prescription (ONYSRx) as a written replacement, or, where an oral-prescribing exception genuinely applies (non-controlled drugs, Schedule III-V, or a bona fide Schedule II emergency), authorize an oral replacement that the pharmacist reduces to writing.
A prescriber who willfully violates the electronic prescribing mandate commits a misdemeanor , punishable by imprisonment and/or a fine of up to $10,000 ; the statute places that burden on the prescriber, with no corresponding penalty written into law for the dispensing pharmacy or pharmacist.
MPJE Application
If a community pharmacist in Buffalo receives a paper prescription for oxycodone dated after March 27, 2016 with no noted exception, the correct response is to decline to fill it and request electronic reissuance (or confirmation that a lawful exception applies) — not to fill it "as written" and not to unilaterally convert it to an electronic record on the prescriber's behalf.